Loading component...
Loading component...
Publications
Read their latest work
Article
The evolving landscape of anti-obesity medication coverage in Medicaid
19 March 2026 - by Amine Elmeghni, Mark F. Gruenhaupt, Kristin Niakan
We expect states to continue balancing the coverage of anti-obesity drugs with immediate budget risks, as cuts to federal Medicaid take effect.
Article
Questions Surrounding Anti-diabetic GLP-1s in Medicaid
12 November 2024 - by Amine Elmeghni, Jim Davidson
As rising utilization of GLP-1s drives up costs, Medicaid and managed Medicaid programs must implement data-driven strategies to manage the financial strain.
